Popular search terms:
Search Results
177 results found-
SMC accepts CSL Behring’s HEMGENIX® (etranacogene dezaparvovec) for use on an interim basis in Scotland as the first single infusion gene therapy for adults with severe or moderately severe haemophilia B without a history of FIX inhibitors
https://www.cslbehring.de/en-us/news/2024/pm-hemgenix-scottland -
Politics meets science: On a campus tour, young talents from research and development gave insights into recent biomedical innovations.
https://www.cslbehring.de/en-us/news/2023/hessens-ministerpraesident-besucht-csl-behring-innovation -
Get to know us and learn more about people, projects and what happens in the world of CSL Behring.
https://www.cslbehring.de/en-us/news/2024/von-der-idee-zur-wirksamen-therapie-6-von-6 -
Researchers from Germany and Switzerland awarded
https://www.cslbehring.de/en-us/news/2022/seven-new-csl-global-research-acceleration-initiative-awardees-announced -
Lernen Sie uns kennen und erfahren Sie mehr über Menschen, Projekte und was in der Welt von CSL Behring passiert.
https://www.cslbehring.de/news/2023/besuch-stark-watzinger-in-m600 -
Get to know us and learn more about people, projects and what happens in the world of CSL Behring.
https://www.cslbehring.de/en-us/news/2023/ibina-zu-gast-in-m600 -
Data Published in the New England Journal of Medicine Confirm the Long-term Durability and Safety of HEMGENIX® (etranacogene dezaparvovec) Over Five Years
https://www.cslbehring.de/en-us/news/2025/pm-hemgenix-long-term-durability-safety -
Neue Preisträger:innen der CSL Global Research Acceleration Initiative bekannt gegeben.
https://www.cslbehring.de/news/2022/seven-new-csl-global-research-acceleration-initiative-awardees-announced -
Get to know us and learn more about people, projects and what happens in the world of CSL Behring.
https://www.cslbehring.de/en-us/news/2023/csl-big-mafex-pitch-day